Merck Chemicals now comprises two new divisions: Merck Millipore and Performance Materials

16-Jul-2010

Merck KGaA announced the successful completion of its acquisition of Millipore Corporation, a leading Life Science company based in Billerica, Massachusetts, USA, for an aggregate purchase price including debt and cash of approximately EUR 5.2 billion (US$ 7.0 billion). Merck agreed to acquire ...

more

Combination will create a € 2.1 billion (US$ 2.9 billion) partner for the Life Science sector and transform Merck Chemicals

02-Mar-2010

Merck KGaA and Millipore Corporation announced that they have entered into a definitive agreement under which Merck KGaA will acquire all outstanding shares of common stock of Millipore, for US$ 107 per share in cash, or a total transaction value, including net debt, of approximately € 5.3 ...

more

John Sweeney to focus on technology development and partnerships

14-Aug-2009

Millipore Corporation announced the appointment of John Sweeney as Vice President of Millipore’s Life Science SBU. Most recently, Sweeney served as Vice President of Strategy and Marketing services for Millipore’s Bioscience Division. Sweeney joined Millipore in 2003 as Director of Strategy and ...

more

Acquisition extends Millipore’s biopharmaceutical services offering to European market

11-Aug-2009

Millipore Corporation announced it has acquired BioAnaLab, a European-based services provider that specializes in the analysis of biologic drugs and vaccines. The transaction enables Millipore to expand its biopharmaceutical services business into Europe and further strengthens its position as a ...

more

17-Apr-2007

Millipore Corporation announced that it is the first company to successfully integrate Radio Frequency Identification (RFID) technology with filtration products used to manufacture biopharmaceutical drugs. The new RFID capability will be branded as SMART Technology and will be introduced at the ...

more

27-Apr-2006

Millipore Corporation and Serologicals Corporation announced that their boards of directors have approved a definitive agreement whereby Millipore will acquire Serologicals in an all cash transaction. The acquisition will transform Millipore into a company with combined annual revenues of ...

more

02-Sep-2005

Millipore and Gen-Probe announced that the companies have formed an alliance to develop, manufacture and commercialize on an exclusive basis nucleic acid testing (NAT) products for rapid microbiological and virus monitoring in the biotech and pharmaceutical industries. Microbiological monitoring ...

more

11-Aug-2005

Millipore Corporation announced that it has completed the acquisition of over 90% of the shares of NovAseptic AB from the company's majority shareholders. Millipore is in the process of acquiring the remaining shares from the minority shareholders. Martin Madaus, Millipore's Chairman, CEO and ...

more

24-Aug-2004

Millipore Corporation announced the official opening of its new $29 million state-of-the-art membrane casting manufacturing facility in Jaffrey, New Hampshire. Adjacent to Millipore's current device plant on Prescott Road, the 44,000-square-foot building will enable Millipore to increase ...

more

05-Mar-2002

BEDFORD, Mass., Mar 4, 2002 -- Millipore Corporation announced it has acquired rights to new technology that enables the sterile filling of biopharmaceutical drugs in a closed, disposable system. The technology was licensed on an exclusive basis for biopharmaceutical applications from Filvek, LLC ...

more